OC-02

Oyster Point Pharma Inks Deal with Ji Xing for Dry Eye Disease Therapies
BioSpace
Sun, 08/8/21 - 12:00 am
Oyster Point Pharma
Ji Xing Pharmaceuticals
OC-01
OC-02
dry eye disease
China
Oyster Point raises $93M series B to bring dry eye nasal spray to FDA
BioCentury
Tue, 02/26/19 - 09:38 am
Oyster Point
dry eye disease
OC-01
OC-02
Hoping to shake Allergan/Shire’s dry eye dominance, Oyster Point posts positive Phase IIb data for rival drug
Endpoints
Thu, 07/12/18 - 11:49 am
Oyster Point
OC-02
dry eye disease
Allergan
Restasis
Shire
Xiidra